Previous Close | 0.2050 |
Open | 0.2050 |
Bid | 0.2050 x 0 |
Ask | 0.2089 x 0 |
Day's Range | 0.2012 - 0.2122 |
52 Week Range | 0.0800 - 0.2700 |
Volume | |
Avg. Volume | 68,720 |
Market Cap | 52.029M |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | Nov 27, 2024 - Dec 02, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or ...
TORONTO, ON / ACCESSWIRE / November 12, 2024 / Theralase® Technologies Inc. ("Theralase ®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or ...